A rush of earnings kept investors busy throughout the morning. Netflix (NFLX) was one of the biggest drags on the Nasdaq and S&P 500 after reporting disappointing subscriber numbers. Benchmark indexes withdrew from records set a day earlier. Johnson & Johnson (JNJ) was the best performer on the Dow Jones Industrial Average after topping estimates in its second quarter and raising its full-year forecasts. A new line of pharmaceutical products helped to boost growth, overshadowing a slide in sales in consumer health. Agricultural company Monsanto (MON) rebuffed a sweetened offer from Bayer (BAYRY) , though it said it was open to further discussions with the company and others interested. Bayer confirmed the improved bid last Thursday. Phillip Morris (PM) sank after reporting a weaker second quarter. The parent of Malboro reported a nearly five percent decline in cigarette volume over the period. TheStreet's Keris Lahiff reports from Wall Street.
More from Video
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.